PDCD1LG2 and melanoma: To assess the mRNA expression of four immunotherapy markers, CD274, PDCD1LG2, CD8A and IRF1, we used a multiplex RT-qPCR immunotherapy panel on the GeneXpert platform in melanoma patients treated with anti-PD-1 therapy.